Literature DB >> 15047058

Studies on sulfatides by quadrupole ion-trap mass spectrometry with electrospray ionization: structural characterization and the fragmentation processes that include an unusual internal galactose residue loss and the classical charge-remote fragmentation.

Fong-Fu Hsu1, John Turk.   

Abstract

The structural characterization of sulfatides by collisional-activated dissociation (CAD) quadrupole ion-trap tandem mass spectrometric methods with electrospray ionization is described. When subjected to CAD in the negative-ion mode, the [M - H]- ions of sulfatides yield abundant structurally informative ions that permit unequivocal assignments of the long-chain base, and fatty acid constituent including the location of double bond. The identification of the position of the double bond on the fatty acyl substituent is based on the observation of the series of the ions arising from classical charge-remote fragmentation processes similar to those observed by high-energy CAD and by tandem quadrupole mass spectrometry. An unusual internal galactose residue loss due to a rearrangement process was also observed. The [M - H]- ions of sulfatides also dissociates to a ceramide anion, which undergoes consecutive fragmentation processes to yield ions informative for identification of the ceramide moiety and permits distinction the sulfatide with a sphingosine subclass from that with a sphinganine long-chain base subclass. The MS(2)-spectra of the sulfatide subclass with a sphingosine LCB and a alpha-hydroxy fatty acyl substituent (d18:1/hFA-sulfatide) are featured by the prominent ion sets of m/z 568, 550, 540, and 522, originated from a primary cleavage of the fatty acyl CO-CH(OH) bond, and are readily differentiable from those arising from the non-hydroxy sulfatide subclass (d18:1/nFA-sulfatide), in which the ion sets are of low abundance. The fragmentation pathways of sulfatides under low-energy CAD are proposed. The pathways are supported by the MS(2)- and MS(3)-spectra of various compounds, and of their H-D exchanged analogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047058     DOI: 10.1016/j.jasms.2003.12.007

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  18 in total

Review 1.  Applications and mechanisms of charge-remote fragmentation.

Authors:  C Cheng; M L Gross
Journal:  Mass Spectrom Rev       Date:  2000 Nov-Dec       Impact factor: 10.946

2.  Fast-atom-bombardment chemistry of sulfatide (3-sulfogalactosylceramide)

Authors:  Y Ohashi; Y Nagai
Journal:  Carbohydr Res       Date:  1991-12-16       Impact factor: 2.104

3.  Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.

Authors:  J Fantini; D Hammache; O Delézay; G Piéroni; C Tamalet; N Yahi
Journal:  Virology       Date:  1998-07-05       Impact factor: 3.616

4.  The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking.

Authors:  P Fredman; J E Mânsson; B M Rynmark; K Josefsen; A Ekblond; L Halldner; T Osterbye; T Horn; K Buschard
Journal:  Glycobiology       Date:  2000-01       Impact factor: 4.313

5.  Characterization of phosphatidylinositol, phosphatidylinositol-4-phosphate, and phosphatidylinositol-4,5-bisphosphate by electrospray ionization tandem mass spectrometry: a mechanistic study.

Authors:  F F Hsu; J Turk
Journal:  J Am Soc Mass Spectrom       Date:  2000-11       Impact factor: 3.109

6.  Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection.

Authors:  T Suzuki; A Sometani; Y Yamazaki; G Horiike; Y Mizutani; H Masuda; M Yamada; H Tahara; G Xu; D Miyamoto; N Oku; S Okada; M Kiso; A Hasegawa; T Ito; Y Kawaoka; Y Suzuki
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

7.  Internal residue loss produced by rearrangement of a novel cationic glycosphingolipid, glyceroplasmalopsychosine, in collision-induced dissociation.

Authors:  Keiko Tadano-Aritomi; Toshiyuki Hikita; Masayuki Kubota; Takeshi Kasama; Kazunori Toma; Sen-Itiroh Hakomori; Ineo Ishizuka
Journal:  J Mass Spectrom       Date:  2003-07       Impact factor: 1.982

8.  Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; G M Campo; M Arlotta; C Quartarone; L Minutoli; M Ferlito; A Saitta; A P Caputi
Journal:  Eur J Pharmacol       Date:  1998-11-13       Impact factor: 4.432

9.  Sulphatide in islets of Langerhans and in organs affected in diabetic late complications: a study in human and animal tissue.

Authors:  K Buschard; K Josefsen; S V Hansen; T Horn; M O Marshall; H Persson; J E Månsson; P Fredman
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

10.  Internal glucose residue loss in protonated O-diglycosyl flavonoids upon low-energy collision-induced dissociation.

Authors:  Y L Ma; I Vedernikova; H Van den Heuvel; M Claeys
Journal:  J Am Soc Mass Spectrom       Date:  2000-02       Impact factor: 3.262

View more
  37 in total

1.  MALDI imaging of lipid biochemistry in tissues by mass spectrometry.

Authors:  Karin A Zemski Berry; Joseph A Hankin; Robert M Barkley; Jeffrey M Spraggins; Richard M Caprioli; Robert C Murphy
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction.

Authors:  Christian Marsching; Mariona Rabionet; Daniel Mathow; Richard Jennemann; Christiane Kremser; Stefan Porubsky; Christian Bolenz; Klaus Willecke; Hermann-Josef Gröne; Carsten Hopf; Roger Sandhoff
Journal:  J Lipid Res       Date:  2014-09-29       Impact factor: 5.922

3.  Characterization of moenomycin antibiotic complex by multistage MALDI-IT/RTOF-MS and ESI-IT-MS.

Authors:  Martin Zehl; Ernst Pittenauer; Andreas Rizzi; Guenter Allmaier
Journal:  J Am Soc Mass Spectrom       Date:  2006-05-30       Impact factor: 3.109

4.  Sulfatides Primarily Exist in the Substantia Nigra Region of Mouse Brain Tissue.

Authors:  Kab-Tae Park; Jong Cheol Shon; Ji-Eun Kim; Gyu Hwan Park; Hyun Jin Choi; Kwang-Hyeon Liu
Journal:  Lipids       Date:  2017-01-11       Impact factor: 1.880

5.  Asymmetric synthesis and structure elucidation of a glycerophospholipid from Mycobacterium tuberculosis.

Authors:  Bjorn Ter Horst; Chetan Seshadri; Lindsay Sweet; David C Young; Ben L Feringa; D Branch Moody; Adriaan J Minnaard
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

6.  Structural studies on archaeal phytanyl-ether lipids isolated from membranes of extreme halophiles by linear ion-trap multiple-stage tandem mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; Simona Lobasso; John Turk; Angela Corcelli
Journal:  Anal Chim Acta       Date:  2013-02-18       Impact factor: 6.558

7.  Imaging of lipid species by MALDI mass spectrometry.

Authors:  Robert C Murphy; Joseph A Hankin; Robert M Barkley
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

8.  Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry.

Authors:  Ying Liu; Yanfeng Chen; Amin Momin; Rebecca Shaner; Elaine Wang; Nathan J Bowen; Lilya V Matyunina; L Deette Walker; John F McDonald; M Cameron Sullards; Alfred H Merrill
Journal:  Mol Cancer       Date:  2010-07-12       Impact factor: 27.401

9.  Immunologic glycosphingolipidomics and NKT cell development in mouse thymus.

Authors:  Yunsen Li; Prakash Thapa; David Hawke; Yuji Kondo; Keiko Furukawa; Koichi Furukawa; Fong-Fu Hsu; Dietlind Adlercreutz; Joel Weadge; Monica M Palcic; Peng G Wang; Steven B Levery; Dapeng Zhou
Journal:  J Proteome Res       Date:  2009-06       Impact factor: 4.466

10.  Elucidation of the double-bond position of long-chain unsaturated fatty acids by multiple-stage linear ion-trap mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; John Turk
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-16       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.